In this study, we found that TP53 and CDKN2A could be involved in the early stage of the stepwise progression of IP to SCC and that the assessment of TP53 and CDKN2A status could be a predictive marker of malignant transformation of IP. The gene discussed is CDKN2A; the disease is incontinentia pigmenti.